Jury selection began Monday in the first bellwether case among nearly 3,000 lawsuits coordinated for pretrial purposes in 2011 before U.S. District Judge Rebecca Doherty in Lafayette, La. A bellwether case is one selected by the parties whose outcome could help resolve issues common to the litigation.
Doherty, of the Western District of Louisiana, is hearing the case against Takeda Pharmaceuticals International Inc. and Eli Lilly and Co., which jointly marketed Actos for treatment of Type II diabetes. A second bellwether trial is scheduled for April 14.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
